Amdocs Limited cash flow to debt ratio of 90.65% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Amdocs Limited's free cash flow has increased 4.23% from $618.93M last year to $645.14M, signaling increasing performance

Amdocs Limited's debt to equity ratio is 0.33, which means that the company's assets are healthy financed, signaling financial stability.

Amdocs Limited's debt has increased relative to shareholder equity from 0.23 last year to 0.33 today, signaling weakened financials

Amdocs Limited has a net debt to EBITDA ratio of 0.54x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Amdocs Limited's interest coverage ratio of 25.58 indicates that earnings with good margin can cover interest payments on company debt

Amdocs Limited's profit margin has decreased (0.84%) in the last year from 9.85% to 9.77%, signaling decreasing performance

Amdocs Limited's short-term assets of $1.59B exceed its short-term liabilities of $1.36B

Amdocs Limited's return on assets of 7.09% is higher than the 5.00% threshold, indicating efficient asset utilization

Amdocs Limited's return on equity of 13.45%, is lower than 15.00%, indicating bad performance

Amdocs Limited's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Amdocs Limited had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Amdocs Limited has positive free cash flow, indicating the company generates cash after capital expenditures

Amdocs Limited has a free cash flow yield of 10.24%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Amdocs Limited's yearly earnings has increased 14.50% since last year from $493.20M to $564.70M, signaling increasing performance

Amdocs Limited's yearly revenue has decreased 9.43% since last year from $5.00B to $4.53B, signaling decreasing performance

ROIC 12.72% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Amdocs Limited's 3-year revenue CAGR of -0.32% is negative, indicating declining revenue over the past 3 years

Amdocs Limited had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Amdocs Limited had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Amdocs Limited is undervalued relative to its fair value price of 90.58 based on Discounted Cash Flow model

Amdocs Limited has an earnings yield of 7.36%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Amdocs Limited is overvalued relative to its fair value price of 55.48 based on EBITDA multiple model

Amdocs Limited has an EV/EBITDA ratio of 7.34x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Amdocs Limited is overvalued relative to its fair value price of 57.11 based on Earnings Fair Value model

Amdocs Limited has a PEG-ratio over 1 which is considered overvalued

Amdocs Limited has a price-to-book ratio of 1.86x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Amdocs Limited has a price-to-sales ratio of 1.33x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue